News | February 14, 2012

Jury Awards $200,000 in Damages in IBA’S RadioMed Trial Against ONC Solutions

February 14, 2012 — A jury awarded RadioMed Corp. $200,000 from ONC Solutions as compensation for ONC using confidential and proprietary information in the development of its products starting in 2007. The case included patented information used in the development of the Visicoil, a gold tumor marker used to better guide radiation therapy.

RadioMed, a subsidiary of Ion Beam Applications (IBA), said it was prepared for any extension to this case should ONC Solutions appeal the verdict.

“We are very pleased the jury recognized the importance of protecting the intellectual property associated with Visicoil”, said Chuck Lindley, RadioMed chief operating officer. “RadioMed has invested significant time and resources in developing this patented cancer treatment technology.”

RadioMed became part of IBA in 2003. Visicoil is a patented (U.S. patent 8,027,712) helically wound gold coil available in various diameters and lengths to aid in the treatment of a range of radiation therapy techniques that target the prostate, lung, liver, pancreas, breast and other organs.

The clinical success of focused, dose-delivery procedures such as image guided radiation therapy (IGRT) and conformal radiation therapy (CRT) is based on the accuracy of target identification and precise patient positioning. Visicoil’s flexible coiled markers allow for accurate tumor localization, using a variety of visualization techniques. Visicoil is a general-purpose implanted fiducial marker. The marker is indicated for use to radiographically mark soft tissue for future therapeutic procedures, per U.S. Food and Drug Administration (FDA) cleared 510(K).

For more information: www.visicoil.com

Related Content

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the...
Overlay Init